Pure Global

Symfony vs Vivity in Dim Light - Trial NCT06229106

Access comprehensive clinical trial information for NCT06229106 through Pure Global AI's free database. This Phase 4 trial is sponsored by Carolina Eyecare Physicians, LLC and is currently Recruiting. The study focuses on Cataract. Target enrollment is 64 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06229106
Phase 4
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06229106
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Symfony vs Vivity in Dim Light
Evaluation of the Symfony With Optiblue Intraocular Lens Compared to The Vivity IOL Under Mesopic Conditions

Study Focus

Cataract

Symfony IOL

Interventional

device

Sponsor & Location

Carolina Eyecare Physicians, LLC

Sarasota,Mount Pleasant, United States of America

Timeline & Enrollment

Phase 4

Dec 01, 2023

Dec 31, 2024

64 participants

Primary Outcome

Binocular distance corrected intermediate visual acuity at 66 cm under mesopic conditions.

Summary

The purpose of this study is to evaluate the visual outcomes of the Symfony lens and the
 Vivity lens under mesopic lighting conditions in adult patients undergoing routine cataract
 surgery. Participants will be asked to read a visual acuity chart at different distances in
 dim light.

ICD-10 Classifications

Other cataract
Cataract, unspecified
Complicated cataract
Other specified cataract
Senile cataract

Data Source

ClinicalTrials.gov

NCT06229106

Device Trial